MiNK Therapeutics Inc INKT Balance Sheet

Income Statement

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	31.12M	25.26M	21.47M	16.59M	12.11M	7.46M	4.55M	6.89M
Total Current Assets	30.33M	24.46M	20.41M	15.52M	11.05M	6.47M	3.6M	6M
Cash and Equivalents	29.85M	24.16M	19.64M	14.89M	10.62M	6.4M	3.37M	5.82M
Total Non-Current Assets	1.58M	1.61M	2.13M	2.13M	2.12M	1.98M	1.91M	1.79M
Total Liabilities	17.43M	18.51M	21.87M	21.07M	21.61M	21.04M	22.61M	27.19M
Total Current Liabilities	17.43M	18.45M	12.68M	11.25M	11.47M	10.4M	11.4M	11.11M
Total Non-Current Liabilities	0	58k	9.19M	9.82M	10.14M	10.65M	11.21M	20.3M
Common Equity	0	0	0	0	0	0	0	0
Retained Earnings	-96.84M	-103.17M	-110.94M	-116.63M	-122.82M	-127.94M	-133.4M	-137.21M

Year End December 30 2023	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	1.31M	4.56M	40.24M	21.47M	4.55M
Total Current Assets	918k	4.1M	39.64M	20.41M	3.6M
Cash and Equivalents	299k	2.69M	38.89M	19.64M	3.37M
Total Non-Current Assets	-36.33M	-53.87M	23.78M	-401k	-18.06M
Total Liabilities	37.64M	58.43M	16.47M	21.87M	22.61M
Total Current Liabilities	7.42M	14.22M	16.47M	12.68M	11.4M
Total Non-Current Liabilities	57.02M	88.03M	0	9.19M	11.21M
Total Equity	-36.33M	-53.87M	23.78M	-401k	-18.06M
Common Equity	0	0	0	0	0
Retained Earnings	-36.5M	-52.74M	-82.95M	-110.94M	-133.4M